Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Tucson, AZ
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Hemet, CA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Hemet, CA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Huntington Beach, CA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
La Jolla, CA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Palm Desert, CA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Palo Alto, CA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Victorville, CA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Victorville, CA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Sarasota, FL
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Boise, ID
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Boise, ID
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Lexington, KY
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Frederick, MD
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Frederick, MD
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Lansing, MI
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Rochester, NY
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Portland, OR
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Duncansville, PA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Seattle, WA
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Research Site
mi
from
Victoria,
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Research Site
mi
from
Victoria,
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Huntsville, AL
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Tuscaloosa, AL
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Peoria, AZ
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Mather, CA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Mather, CA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Murrieta, CA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Palm Desert, CA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Palm Desert, CA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Tustin, CA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Tustin, CA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Upland, CA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Jupiter, FL
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Jupiter, FL
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Tamarac, FL
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Tampa, FL
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Gainesville, GA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Meridian, ID
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Springfield, IL
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Springfield, IL
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Bowling Green, KY
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Bowling Green, KY
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Somerset, KY
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Somerset, KY
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Frederick, MD
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Frederick, MD
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Wheaton, MD
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Wheaton, MD
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Worcester, MA
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Lansing, MI
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Lansing, MI
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Eagan, MN
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Eagan, MN
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Omaha, NE
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Clifton, NJ
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Clifton, NJ
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Great Neck, NY
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
New York, NY
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Plainview, NY
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Plainview, NY
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Asheville, NC
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Bend, OR
Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials